What causes cataracts? An expert explains the common eye disease and treatment options.
Carytosis is a common eye condition that can lead to cataracts, which are serious eye disorders characterized by weak lens-shaped eyes. Here's an organized overview of the topic:
1. What Causes Carytosis?
- Carytosis arises when there is astigmatism in the eye, particularly on the corneum (the cloudy covering around the lens). This causes light to spread unevenly across the lens, weakening it over time.
2. Progression of Carytosis into Cataracts:
- In one eye, carytosis typically progresses within 1–3 years, leading to a loss in focal power and eventual development of a myopic (nearsighted) or hyperopic (farsighted) effect.
- In the other eye, pre-irradiation carytosis can lead to additional progression, contributing to both cataracts.
3. Symptoms:
- Common symptoms in one eye include leftward visual displacement, tiredness, and fatigue.
- In the opposite eye, rightward displacement may occur.
4. Treatment Options:
- Laser Treatment: Effective for pre-irradiation carytosis and can sometimes correct post-irradiation issues.
- Artificial Eyes: Can reduce myopia over time or cause irreversible damage in older individuals if not used correctly.
- Surgery (Myotomy): May be necessary in some cases, especially when no other treatments work.
5. When to Seek Help:
- Regular eye exams should occur during Carytosis Awareness Month to identify pre-irradiation or post-irradiation issues early.
- Younger adults may benefit from biopsies for further diagnosis.
6. Preventative Tips:
- Wear appropriate glasses with correct lenses (lens-to-cornea distance) and correct佩戴 habits.
- Avoid heavy sports, as prolonged activity can affect vision in both eyes.
In summary, carytosis is a significant condition affecting millions of Americans, leading to cataracts. Early detection and treatment options, including laser therapy, artificial eyes, and surgery, are crucial. Regular eye exams during Awareness Month help ensure proper care for those affected.
------
Topic Live





